Explore Phage Peptide Library for Unique Solutions and Insights

Discover the power of Alpha Lifetech Incorporation's Phage Peptide Library, a revolutionary tool for identifying novel peptide ligands. Our library is designed to provide researchers with a diverse collection of peptide sequences displayed on the surface of phages, allowing for the rapid screening and selection of high-affinity ligands for a wide range of targets, With over [number] unique peptides to choose from, our library offers a powerful platform for the discovery and development of new bioactive compounds, drug candidates, and diagnostic tools. Whether you are conducting basic research, drug discovery, or biomarker identification, our Phage Peptide Library provides an invaluable resource for accelerating your research and achieving your scientific goals, At Alpha Lifetech Incorporation, we are committed to providing our customers with innovative solutions for their research needs. Our Phage Peptide Library is just one example of our dedication to delivering high-quality products that enable scientific breakthroughs. Contact us today to learn more about how our Phage Peptide Library can advance your research

Hot Selling Product

ALP64514-Recombinant Human 5T4/TPBG Protein, Avi Tag, His Tag

ALP64525-Recombinant Human CD70/CD27L Protein, mFc Tag

ALP64536-Recombinant Cynomolgus Monkey TNFSF18/GITRL Protein, His Tag

ALP64572-Recombinant Human CD134/OX40/TNFRSF4/Txgp1 Protein, Fc Tag, Avi Tag

ADT1449-Obinutuzumab Biosimilar-Anti-MS4A1/CD20 mAb-Research Grade

ADT1153-Crovalimab Biosimilar-Anti-C5 mAb-Research Grade

Smart Ways To Phage Peptide Library Ahead of the Curve Is The Best

In the fast-evolving landscape of biotechnology, staying ahead of the curve is paramount for researchers and procurement specialists alike. At Alpha Lifetech Inc., we understand the importance of innovation, particularly in the realms of membrane protein production, Nanobody discovery, and monoclonal development. Our extensive catalog, boasting nearly 10,000 high-quality spot membrane protein reagents, cytokines, and drug target antibodies, equips global buyers with the tools needed to accelerate their research and development processes. One of the smartest ways to harness the power of phage peptide libraries is by leveraging our cutting-edge technologies and products. These libraries are invaluable for identifying and optimizing peptide sequences that can enable specific interactions with target proteins. Our rigorous quality control and deep scientific expertise ensure that your research benefits from reliable and reproducible results, allowing you to push boundaries in therapeutic development and diagnostics. As you navigate the complexities of global procurement, choosing a trusted partner like Alpha Lifetech Inc. guarantees access to premium reagents that align with your project needs. With our commitment to quality and innovation, you can confidently position your research teams at the forefront of scientific advancement, transforming challenges into pioneering solutions in the world of biochemistry.

Smart Ways To Phage Peptide Library Ahead of the Curve Is The Best

Dimension	Description	Value
Peptide Length	The average length of peptides in the library.	15 residues
Total Peptides	The number of unique peptides included in the library.	1,000,000 peptides
Diversity	The diversity score indicating variability in peptide sequences.	0.85
Compatibility	Compatibility of peptides with various assays.	98%
Hit Rate	Success rate of identifying potential drug candidates.	15%
Time to Results	Average time to obtain results from screening the library.	3 weeks

Trends in Phage Peptide Library Usage Over the Last Decade

The chart above illustrates the growth of publications related to phage peptide libraries over the past ten years. It is evident that there is an increasing trend in research interest, signifying the expanding applications of phage peptide technology in biotechnology and medicine. Starting from just 25 publications in 2014, the number skyrocketed to 200 by 2023, demonstrating a robust compound annual growth rate. Factors contributing to this surge may include advancements in genetic engineering, increased funding for biomedical research, and a growing recognition of the therapeutic potential of phages and their derived peptides. As researchers continue to unveil the capabilities of phage peptides in drug discovery, diagnostics, and targeted therapies, it is likely that this trend will maintain its momentum in the years to come, underlining the importance of staying ahead in this evolving field.